Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Interface Biosciences Logo
Interface Biosciences Growth Score
1
CB Rank
256938
Heat Score
62
Interface Biosciences is a platform therapeutics company that specializes in using the microbiome to treat inflammatory diseases.
Founded
obfuscation
PrivateSeed Palo Alto, California, United States1-10 interface.bio
Biotechnology
Health Care
Therapeutics
Overview

Interface Biosciences
Growth Score
1
Heat Score
62

Growth Score1
-3 pts
in past quarter
Heat Score 62
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Interface Biosciences

CB Rank
256938
Interface Biosciences is a platform therapeutics company that specializes in using the microbiome to treat inflammatory diseases.
Founded
obfuscation
PrivateSeed Palo Alto, California, United States1-10 interface.bio
Biotechnology
Health Care
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Key People

  • Photo of Hannah Wastyk
    Hannah Wastyk: Co-founder and CEO
    Past Role: University of Delaware, Teaching Assistant for Introductory Chemistry Laboratory
  • Photo of Will Van Treuren
    Will Van Treuren: Co-founder and CSO
    Past Role: Biota Technology, Consultant

Details

Operating Status Active
Company Type For Profit
Founders  Hannah Wastyk, Will Van Treuren
Contact Email hannah@interface.bio
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

AI-Guided Sactipeptide Discovery Platform
A platform that uses AI to identify and characterize novel sactipeptides with drug-like properties for therapeutic development.
Microbial-Derived Natural Product Library Construction
A service that builds libraries of microbial natural products with potential bioactivity for drug discovery.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed
obfuscation
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
2
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Ulu Ventures Logo
Ulu Ventures
—
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
—
Ulu Ventures Logo
Ulu Ventures
—
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
—
Ulu Ventures Logo
Ulu Ventures
—
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
—
Ulu Ventures Logo
Ulu Ventures
—
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
—
Ulu Ventures Logo
Ulu Ventures
—
Seed Round - Interface Biosciences Logo
Seed Round - Interface Biosciences
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 3

Employee Profiles

News

News and Press

News•Oct 17, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

560
956.6%
 in past month

IT Spend

$183.9KThis year, Interface Biosciences is projected to spend $183.9K on IT, according to Aberdeen.

Active Website Tech Count

12Interface Biosciences is actively using 12 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Interface Biosciences's headquarters? Interface Biosciences is located in Palo Alto, California, United States.Who invested in Interface Biosciences? Interface Biosciences has 5 investors including Ulu Ventures and  LongeVC.When was the last funding round for Interface Biosciences? Interface Biosciences closed its last funding round on
obfuscation
from a Seed round.Who are Interface Biosciences's competitors? Alternatives and possible competitors to Interface Biosciences may include MaaT Pharma, Vedanta Biosciences, and  Microbiotica.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|